CD86 and central nervous system cancer: The enhanced activation markers, CD83 and CD86, found in DCs pulsed with PDT F/T IR- versus IR-only-treated lysates, Figure 2, resemble findings in 5-ALA/PDT-treated glioma spheroids, although activation there was not compared to the irradiated samples [38].